Cargando…

Effectiveness and Safety of Pirfenidone and Nintedanib for Pulmonary Fibrosis in COVID-19-Induced Severe Pneumonia: An Interventional Study

Background After a diagnosis of two to five years, the survival length for pulmonary fibrosis (PF) is considered to be medium. The primary objective of PF treatment is to stabilize or minimize the pace of progression of the illness. The treatment of PF by nintedanib and pirfenidone was a breakthroug...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhary, Rajkamal, Kumar, Abilesh, Ali, Obaid, Pervez, Anjum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587348/
https://www.ncbi.nlm.nih.gov/pubmed/36299940
http://dx.doi.org/10.7759/cureus.29435